Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $672.19 billion, total revenue of $168.86 billion and a weighted average PE ratio of 38.41.
Market Cap
672.19B
Revenue
168.86B
Profits
17.5B
PE Ratio
38.41
Profit Margin
10.36%
Dividend Yield
0.24%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 172.66B | 0.63% | 3,358,519 | 45.20B |
| 2 | DHR | Danaher Corporation | 125.40B | -0.33% | 7,258,516 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.34B | 2.93% | 1,240,834 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 35.89B | 2.20% | 4,334,342 | 7.23B |
| 5 | WAT | Waters Corporation | 34.90B | -0.44% | 1,460,782 | 3.77B |
| 6 | NTRA | Natera, Inc. | 33.14B | 2.19% | 2,630,814 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 28.00B | -1.70% | 3,703,602 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 24.50B | 1.79% | 3,100,569 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.13B | 1.36% | 254,458 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.59B | -1.40% | 1,292,235 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 20.98B | -1.44% | 1,249,802 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.47B | 2.07% | 3,408,835 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.14B | 0.68% | 472,653 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 11.18B | 1.91% | 870,048 | 8.25B |
| 15 | RVTY | Revvity, Inc. | 11.16B | 2.23% | 2,169,763 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.91B | 1.46% | 1,170,070 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.64B | 1.01% | 1,964,093 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 5.45B | 5.66% | 3,938,493 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 4.84B | 5.81% | 985,014 | 354.54M |
| 20 | SHC | Sotera Health Company | 4.51B | 2.33% | 3,180,975 | 1.19B |
| 21 | VCYT | Veracyte, Inc. | 4.28B | 4.56% | 4,155,430 | 541.74M |
| 22 | RDNT | RadNet, Inc. | 4.23B | 1.74% | 2,522,407 | 2.14B |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 2.81B | 4.47% | 3,882,994 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.74B | 7.22% | 1,164,791 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.75B | 4.59% | 658,564 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.45B | 7.23% | 6,964,953 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.35B | 11.50% | 2,744,335 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.10B | 8.10% | 3,823,040 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.07B | 0.71% | 5,231,778 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 640.57M | 4.30% | 726,610 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 511.21M | 1.69% | 684,420 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 428.79M | 3.65% | 2,436,337 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 344.98M | 3.22% | 140,303 | 120.07M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 175.65M | 2.26% | 694,708 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 169.93M | 10.45% | 132,408 | 96.10M |
| 36 | XGN | Exagen Inc. | 109.69M | 6.82% | 304,684 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 76.46M | 2.98% | 26,094 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 40.13M | 0.40% | 38,665 | 25.83M |
| 39 | MDXH | MDxHealth SA | 27.89M | -3.33% | 327,638 | 110.97M |
| 40 | QUCY | Quantum Cyber N.V. | 25.80M | -7.37% | 1,786,273 | 537.08K |
| 41 | MBAI | Check-Cap Ltd. | 10.42M | 5.15% | 54,893 | - |
| 42 | XWEL | XWELL, Inc. | 10.05M | -1.22% | 94,635 | 28.83M |
| 43 | ADVB | Advanced Biomed Inc. | 8.43M | 7.37% | 16,548 | - |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.91M | - | 4,077 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.79M | 0.65% | 827,387 | 5.66M |
| 46 | ISPC | iSpecimen Inc. | 3.72M | 1.57% | 106,613 | 1.03M |